Introduction

This statement is made pursuant to Section 54 of the Modern Slavery Act 2015 and sets out the steps that Amethyst Radiotherapy UK has taken, and continues to take, to prevent modern slavery and human trafficking within its business and supply chains. This statement covers the financial year ending 2026.

Statement

As a provider of radiotherapy services, Amethyst Radiotherapy UK recognises its responsibility to uphold the highest standards of ethical conduct, human rights, and safeguarding. Modern slavery and human trafficking are serious crimes and violations of fundamental human rights and are incompatible with NHS values and the delivery of safe, effective, and compassionate patient care. We operate a zero-tolerance approach to modern slavery and human trafficking and are committed to acting ethically, transparently and with integrity across all clinical and non-clinical operations.

Amethyst Radiotherapy UK is committed to complying with Service Condition 12 (SC12) of the NHS Standard Contract, which requires providers to comply with the Modern Slavery Act 2015, take appropriate steps to ensure that modern slavery and human trafficking do not take place in their business or supply chains, maintain and publish a modern slavery statement where required, and cooperate with commissioners in relation to any investigations or assurance activities concerning modern slavery risks. This statement forms part of our wider governance, safeguarding, and ethical procurement framework.

Supply Chain

Amethyst Radiotherapy UK delivers specialist radiotherapy services within regulated healthcare environments, supported by clinical, technical, and corporate functions. Our supply chains are diverse and include clinical and non-clinical staffing, including agency, bank, and temporary workers; medical and radiotherapy equipment, devices, and maintenance services; pharmaceuticals, consumables, and radiation safety equipment; estates, facilities management, cleaning, catering, and security services; and IT systems and professional support services. We recognise that certain areas, particularly labour supply chains and the overseas manufacturing of medical devices and equipment, may present increased risks of modern slavery. These risks are assessed proportionately and managed in line with NHS guidance.

We undertake proportionate due diligence processes when engaging new suppliers and renewing contracts. This includes risk-based supplier assessments, particularly for higher-risk categories such as labour providers and overseas manufacturers and requiring suppliers to confirm compliance with the Modern Slavery Act 2015 and the NHS Supplier Code of Conduct. Our standard procurement processes incorporate contractual clauses addressing modern slavery risks, and we carry out ongoing monitoring of supplier performance where appropriate. Where risks are identified, we seek to work collaboratively with suppliers to support remediation and improvement; however, we reserve the right to terminate relationships with suppliers who fail to meet required standards.

We recognise that modern slavery risks may arise both within our operations and across our supply chains. Within our organisation, risks may relate to recruitment practices and the use of agency or temporary staff. Within our supply chains, risks may arise from the procurement of goods manufactured overseas or the use of outsourced services such as cleaning, catering, and facilities management. These risks are assessed through procurement processes, safeguarding systems, and management oversight and are reviewed periodically through our governance structures.

In line with the NHS Supplier Code of Conduct and NHS Standard Contract requirements, we expect all suppliers, contractors, and business partners to prohibit the use of forced, compulsory, or trafficked labour; ensure fair pay, lawful working hours, and ethical recruitment practices; comply with all applicable employment, health and safety, and safeguarding legislation; and apply equivalent standards throughout their own supply chains. Where risks are identified, we work with suppliers, where appropriate, to support remediation and continuous improvement in line with NHS principles.

Monitoring Effectiveness

We monitor the effectiveness of our approach to preventing modern slavery through a range of measures, including reviewing safeguarding and incident reporting data, monitoring supplier compliance and risk assessments, tracking staff training completion, and undertaking periodic reviews of relevant policies and procedures. We recognise that our approach will continue to evolve, and we are committed to developing more formal key performance indicators as our processes mature.

This policy applies to all individuals working for or on behalf of Amethyst Radiotherapy UK, including employees, directors, agency and temporary staff, contractors, consultants, and suppliers. It does not form part of any contract of employment and may be reviewed and amended as required.

Accountability

The Board of Directors of Amethyst Radiotherapy UK retains overall accountability for compliance with the Modern Slavery Act 2015 and NHS Standard Contract requirements, including Service Condition 12. Senior management is responsible for implementing this policy, overseeing compliance, and integrating modern slavery risk management into recruitment, procurement, contract management, and clinical governance processes. Managers are responsible for ensuring that staff understand this policy and receive appropriate training, particularly those involved in recruitment, supplier engagement, and procurement decisions.

All individuals working for or on behalf of Amethyst Radiotherapy UK are responsible for remaining vigilant to the risks of modern slavery and human trafficking. Any concerns or suspicions must be reported promptly through established internal reporting routes, including line management or senior leadership, and may also be raised through safeguarding or whistleblowing procedures in line with NHS expectations and the Public Interest Disclosure Act. We are committed to fostering a culture of openness and will support anyone who raises a concern in good faith, ensuring that no individual suffers detriment as a result.

Training and Awareness

Training and awareness are fundamental to our approach. Training on modern slavery risks and this policy forms part of staff induction and is refreshed periodically, particularly for those working in recruitment, procurement, and contract management roles. Our zero-tolerance approach is communicated clearly to suppliers and business partners at the outset of engagement and reinforced through contractual and governance processes.

This modern slavery statement has been signed off by the Amethyst UK CEO 

 Amethyst Radiotherapy UK is committed to continuous improvement in its approach to tackling modern slavery. We will continue to strengthen our processes by enhancing visibility across our supply chains, particularly beyond tier-one suppliers, further developing supplier risk assessment and monitoring processes, expanding training and awareness programmes, and ensuring alignment with evolving NHS and regulatory expectations.